600566 Hubei Jumpcan Pharmaceutical
- 30.85
- +0.11+0.36%
Hubei Jumpcan Pharmaceutical News
Announcement of the progress of Hubei Jichuan Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding transactions
Announcement of the progress of Hubei Jichuan Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding transactions
Announcement of the progress of Hubei Jichuan Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding transactions
Announcement of Hubei Jichuan Pharmaceutical Co., Ltd. on repurchasing shares for the first time through centralized bidding
Announcement of Partial Options Cancellation of the Restricted Stocks and Stock Options Incentive Plan for 2022 of Hubei Jumpcan Pharmaceutical Co., Ltd.
Legal Opinion of Guohao Law Firm (Shanghai) on the Cancellation of Restricted Stock Options and Repurchase of Restricted Stocks of Hubei Jumpcan Pharmaceutical Co., Ltd.'s 2022 Restricted Stock and Stock Option Incentive Plan.
Announcement of Hubei Jumpcan Pharmaceutical Co., Ltd. on the implementation of the cancellation of restricted share buyback of 2022 restricted stock and stock option incentive plan.
Announcement on the Progress of Repurchasing Shares by Hubei Jumpcan Pharmaceutical Co., Ltd. through Centralized Competitive Trading
Hubei Jumpcan Pharmaceutical: Legal opinion from Guohao Law Firm (Shanghai) regarding the cancellation of some stock options and repurchase of restricted stocks under Hubei Jumpcan Pharmaceutical Co., Ltd.'s 2022 restricted stock and stock option incentive plan.
Announcement and Repurchase Report of Hubei Jumpcan Pharmaceutical Co., Ltd. on Repurchasing Company Shares by Centralized Bidding Trading Method
Legal opinion from Guohao Law Firm (Shanghai) regarding the cancellation of some stock options and repurchase of restricted stocks under Hubei Jumpcan Pharmaceutical Co., Ltd.'s 2022 restricted stock and stock option incentive plan.
Announcement on cancellation of some stock options and repurchase of restricted stocks by Hubei Jumpcan Pharmaceutical Co., Ltd.
Announcement on the implementation of share repurchase and changes in shareholding of Hubei Jumpcan Pharmaceutical Co., Ltd.
Hubei Jumpcan Pharmaceutical Co., Ltd.'s annual equity distribution implementation announcement for 2023.
Announcement of Hubei Jumpcan Pharmaceutical Co., Ltd. regarding the adjustment of the maximum repurchase price after the implementation of the annual equity distribution in 2023.
Announcement on the Progress of Repurchasing Shares by Hubei Jumpcan Pharmaceutical Co., Ltd. through Centralized Competitive Trading
Announcement of Hubei Jichuan Pharmaceutical Co., Ltd. on completing the non-transactional transfer of the 2024 employee stock ownership plan
Announcement of the progress of Hubei Jichuan Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding transactions
Hubei Jichuan Pharmaceutical Co., Ltd. 2023 Profit Distribution Plan Announcement
Announcement of the progress of Hubei Jichuan Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding transactions
Analysis
Price Target
No Data
No Data